Biotech
UPDATE: Kaleido Confirms Layoffs, Halts Planned Phase 2 and Appears to Have Ended COVID-19 Program
UPDATE: Kaleido confirms layoffs, halts planned phase 2 and appears to have ended COVID-19 program
klahucik
Fri, 01/28/2022 – 14:37
Read More
Original Source: fiercebiotech.com
SKYLARK sings: Sage, Biogen hatch positive phase 3 data in postpartum depression
ntaylor
Wed, 06/01/2022 – 07:39Read More
Original Post: fiercebiotech.com
BioMarin’s hemophilia A gene therapy further delayed amid new FDA questions
mbayer
Wed, 06/01/2022 – 10:06Read More
Original Post: fiercebiotech.com
Sanofi’s Hemlibra rival gets step closer to approval with FDA breakthrough tag
jwaldron
Wed, 06/01/2022 – 09:55Read More
Source: fiercebiotech.com
-
Health News6 months agoIMA Delegation Meets Dr Raj Bahadur
-
Banking1 year ago
New CEO, Chairman to Lead Puratos in 2022
-
Banking12 months ago
Puratos Accelerates Well-being Strategy Through Acquisition
-
World1 year ago
Tips for Teachers January 27, 2022
-
Biotech12 months ago
Gilead’s CD47 Clinical Hold Expands As CEO O’Day Expresses ‘sense of Urgency’ in Getting Trials Back on Track
-
World11 months ago
How the Letter ‘Z’ Fits Into the History of Russian Propaganda Efforts
-
Health News1 year ago
Army Adopts 26 Girls of Nari Niketan in Poonch
-
World1 year ago
Leprosy: Forgotten, but Not Gone
